ClinicalBiostats

11 · Therapeutic Area

Gastroenterology & Hepatology Clinical Trials

Inflammatory bowel disease, liver disease and other digestive-disorder trials, with remission endpoints and categorical comparisons.

455 trials in this area

Statistical methods in gastroenterology & hepatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

Cochran-Mantel-Haenszel test Used in 22% of gastroenterology & hepatology trials · SAS PROC FREQ for Categorical Data Analysis → Risk difference Used in 16% of gastroenterology & hepatology trials · Effect Size Measures in Clinical Research → ANCOVA Used in 12% of gastroenterology & hepatology trials · Analyzing Change from Baseline in Clinical Trials → Non-inferiority trial design Used in 10% of gastroenterology & hepatology trials · Non-Inferiority Trial Design Principles → Multiple imputation / missing data Used in 7% of gastroenterology & hepatology trials · Multiple Imputation: A Practical Guide → Odds ratio Used in 7% of gastroenterology & hepatology trials · Effect Size Measures in Clinical Research → Fisher exact test Used in 6% of gastroenterology & hepatology trials · Fisher's Exact Test for Small Sample Sizes → Mixed-effects model Used in 6% of gastroenterology & hepatology trials · Linear Mixed Effects Models for Longitudinal Data →

All gastroenterology & hepatology trials

455 results

← All therapeutic areas